| |
Article Title |
Author(s) |
Type (Status) |
Available Online |
|
From the Editor March/April 2012 Issue
DOI: 10.1016/j.jacl.2012.01.005
|
W. Virgil Brown
|
Editorial
(In Press Accepted Manuscript)
|
30 January 2012 |
|
Compared with traditional lipid parameters, non-high density lipoprotein cholesterol was associated with albuminuria more closely in Chinese type 2 diabetic patients with normal renal function
DOI: 10.1016/j.jacl.2012.01.008
Abstract: Background: Urinary albumin excretion rate (UAER) is a remarkable index reflecting the progression of kidney disease in diabetic subjects. The linkage between UAER and lipid metabolism is st...
|
Jiemin Pan,
Fei Gao,
Yuqian Bao,
Lei Zhang,
Yinfang Tu,
Weiping Jia
et al.
|
Full-length article
(In Press Accepted Manuscript)
|
30 January 2012 |
|
Novel missense variants in LCAT and APOB genes in an Italian kindred with familial LCAT deficiency and hypobetalipoproteinemia
DOI: 10.1016/j.jacl.2012.01.006
Abstract: Background: Lecithin:cholesterol acyltransferase (LCAT) is responsible for cholesterol esterification in plasma. Mutations of LCAT gene cause familial LCAT deficiency, a metabolic disorder c...
|
Paola Conca,
Silvana Pileggi,
Sara Simonelli,
Emanuela Boer,
Giuliano Boscutti,
Lucia Magnolo,
Patrizia Tarugi,
Silvana Penco,
Guido Franceschini,
Laura Calabresi,
Monica Gomaraschi
et al.
|
Full-length article
(In Press Accepted Manuscript)
|
30 January 2012 |
|
Significant reduction of elevated serum lipoprotein(a) concentrations during levo-thyroxine replacement therapy in a hypothyroid patient
DOI: 10.1016/j.jacl.2012.01.007
Abstract: A number of previous studies have reported the effect of the thyroid status on the changes of the serum lipids, whereas on serum Lp(a) concentrations have been limited and the results are co...
|
Toshio Murase,
Sadao Arimoto,
Minoru Okubo,
Shinichi Morinaga
|
Short communication
(In Press Accepted Manuscript)
|
30 January 2012 |
|
Plasma exchange for severe hypertriglyceridemia-induced pancreatitis in an orthotopic heart transplantation recipient
DOI: 10.1016/j.jacl.2012.01.003
Hypertriglyceridemia (HTG) is a well-known cause of pancreatitis. The most popular theory explaining HTG-induced pancreatitis involves the release of free fatty acids from triglycerides (TGs) by pancr...
|
Danesh K. Kella,
Sana Shoukat,
Laurence Sperling
|
Short communication
(In Press Uncorrected Proof)
|
24 January 2012 |
|
Lipoprotein(a) particle concentration and lipoprotein(a) cholesterol assays yield discordant classification of patients defining four physiologically discrete groups
DOI: 10.1016/j.jacl.2012.01.004
Abstract: There is little known about the relative predictive value of different lipoprotein(a) [Lp(a)] assays in clinical use, although each has been shown to predict similar incremental risk over co...
|
Matthew Konerman,
Krishnaji Kulkarni,
Peter P. Toth,
Steven R. Jones
|
Full-length article
(In Press Uncorrected Proof)
|
24 January 2012 |
|
A meta-analysis of randomized controlled trials comparing lipid effects of beef with poultry and/or fish consumption
DOI: 10.1016/j.jacl.2012.01.001
Abstract: Background: : Limited consumption of red meat, including beef, is one of many often suggested strategies to reduce risk for coronary heart disease. However, the role beef consumption, specif...
|
Kevin C. Maki,
Mary E. Van Elswyk,
Dominik D. Alexander,
Tia M. Rains,
Eugenia L. Sohn,
Shalene McNeill
et al.
|
Full-length article
(In Press Accepted Manuscript)
|
24 January 2012 |
|
A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Evaluation of COPD Longitudinally to Identify Surrogate Endpoints) study
DOI: 10.1016/j.jacl.2012.01.002
Background: Omega-3 (OM-3) fatty acid products are indicated for the treatment of severe hypertriglyceridemia; however, the omega-3-acid ethyl ester (OM-3 EE) formulations require significant pancreat...
|
Michael H. Davidson,
Judith Johnson,
Michael W. Rooney,
Douglas F. Kling
|
Full-length article
(In Press Uncorrected Proof)
|
24 January 2012 |
|
Genotype–phenotype correlation related to lipid profile in beta-thalassemia major and intermedia in southern Iran
DOI: 10.1016/j.jacl.2011.12.005
Background: Beta-thalassemia is commonly associated with lipid abnormalities. The aim of this study was to search for links between these lipid alterations and different types of β-thalassemia mutatio...
|
Mohammadreza Bordbar,
Sezaneh Haghpanah,
Abdolreza Afrasiabi,
Javad Dehbozorgian,
Mehran Karimi
et al.
|
Full-length article
(In Press Corrected Proof)
|
28 December 2011 |
|
Difference between calculated and direct-measured low-density lipoprotein cholesterol in subjects with diabetes mellitus or taking lipid-lowering medications
DOI: 10.1016/j.jacl.2011.12.007
Objective: We evaluated factors that caused differences between calculated low-density lipoprotein cholesterol (C-LDL-C) and direct-measured LDL-C (D-LDL-C) and compared them in subjects with diabetes...
|
Su-Yeon Choi,
Hyo Eun Park,
Min-Kyung Kim,
Chan Soo Shin,
Sang-Heon Cho,
Byung-Hee Oh
et al.
|
Full-length article
(In Press Corrected Proof)
|
26 December 2011 |
|
Elevation of fasting morning glucose relative to hemoglobin A1c in normoglycemic patients treated with niacin and with statins
DOI: 10.1016/j.jacl.2011.12.008
Background: Niacin increases fasting glucose levels, and statins modestly increase the rate of new-onset diabetes. The clinical importance and mechanisms of these effects are not fully explored. Objec...
|
Veena Rajanna,
Kristen B. Campbell,
Jeffrey Leimberger,
Bibhu D. Mohanty,
John R. Guyton
et al.
|
Full-length article
(In Press Corrected Proof)
|
26 December 2011 |
|
Pregnancy during adolescence has lasting adverse effects on blood lipids: A 10-year longitudinal study of black and white females
DOI: 10.1016/j.jacl.2011.12.004
Background: Primiparity has been associated with 3 to 4 mg/dL lower high-density lipoprotein cholesterol concentrations in black and white adult women that persist several years after delivery. Object...
|
Erica P. Gunderson,
George Schreiber,
Ruth Striegel–Moore,
Mark Hudes,
Stephen Daniels,
Frank M. Biro,
Patricia B. Crawford
et al.
|
Full-length article
(In Press Corrected Proof)
|
26 December 2011 |
|
The use of lipopheresis in the practice of clinical lipidology†
DOI: 10.1016/j.jacl.2011.12.003
W. Virgil Brown, MD: In this issue of the Journal, I have invited three clinical lipidologists who are treating patients with very high LDL concentrations using devices that physically remove apolipop...
|
W. Virgil Brown,
Robert Brook,
Linda C. Hemphill,
Patrick M. Moriarty
|
Review article
(In Press Uncorrected Proof)
|
23 December 2011 |
|
Polish Lipid Association – A strong response to the problem of lipid disorders in Poland and Central and Eastern Europe
DOI: 10.1016/j.jacl.2011.12.002
As a group, lipid disorders constitute one of the most important and common risk factors for atherosclerotic disease. According to the cardiovascular continuum theory, lipid disorders promote the deve...
|
Maciej Banach,
Michael Davidson,
Peter P. Toth
|
Editorial
(In Press Corrected Proof)
|
12 December 2011 |
|
Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction
DOI: 10.1016/j.jacl.2011.11.007
Background: Recent trends suggest a decreased use of ezetimibe/simvastatin combination and coadministered ezetimibe plus statin therapies. Objective: This analysis evaluated changes in prescription pa...
|
Peter P. Toth,
Christie M. Ballantyne,
Michael H. Davidson,
Joanne E. Tomassini,
Dena Rosen Ramey,
David Neff,
Andrew M. Tershakovec,
X. Henry Hu,
Kaan Tunceli
et al.
|
Full-length article
(In Press Corrected Proof)
|
08 December 2011 |
|
Relationship between serum uric acid and metabolic syndrome: An analysis by structural equation modeling
DOI: 10.1016/j.jacl.2011.11.006
Objective: To investigate the nature of the relationships between uric acid and metabolic syndrome (MetS) components. Methods: Body mass index, waist circumference, serum uric acid, fasting glucose, l...
|
Wenli Lu,
Kun Song,
Yuan Wang,
Qing Zhang,
Wen Li,
Huanli Jiao,
Guolin Wang,
Guowei Huang
et al.
|
Full-length article
(In Press Corrected Proof)
|
06 December 2011 |
|
Low-density lipoprotein apheresis is effective in reducing lipoprotein (a) levels and in improving symptoms in a patient with refractory angina secondary to accelerated coronary artery disease
DOI: 10.1016/j.jacl.2011.11.003
Abstract: Coronary artery disease remains a significant cause of morbidity and mortality in the Western world. High plasma Lp(a) concentrations are related to the risk of cardiovascular disease, but L...
|
Michael Ibrahim,
Bassey Ussen,
Alison Pottle,
Mahmoud Barbir
|
Short communication
(In Press Corrected Proof)
|
05 December 2011 |
|
Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia
DOI: 10.1016/j.jacl.2011.11.004
Background: The use of extended-release niacin and the prostaglandin D2 receptor antagonist laropiprant (ERN/LRPT) reduces niacin-induced flushing in patients while preserving its lipid-modifying effe...
|
Christie Ballantyne,
Gilbert Gleim,
Nancy Liu,
Christine McCrary Sisk,
Amy O. Johnson-Levonas,
Yale Mitchel
et al.
|
Full-length article
(In Press Corrected Proof)
|
05 December 2011 |
|
The relationship between subclinical atherosclerosis, non–high-density lipoprotein cholesterol, exercise, and diet among male participants of the PACC Project
DOI: 10.1016/j.jacl.2011.11.005
Background: Non-high-density lipoprotein (HDL) cholesterol is recommended as a secondary lipid goal treated initially with lifestyle modification. However, the relationship between non-HDL and subclin...
|
Lauren A. Simprini,
Todd C. Villines,
Michael Rich,
Allen J. Taylor
|
Full-length article
(In Press Corrected Proof)
|
05 December 2011 |
|
The high-dose rosuvastatin once weekly study (The HD-ROWS)
DOI: 10.1016/j.jacl.2011.11.002
Background: Alternative dosing is often used clinically to address common barriers with statin therapy, such as intolerance and cost. Previous findings have demonstrated significant and clinically sim...
|
James M. Backes,
Cheryl A. Gibson,
Janelle F. Ruisinger,
Patrick M. Moriarty
|
Full-length article
(In Press Corrected Proof)
|
21 November 2011 |
|
Search and rescue for hypotheses surviving AIM-HIGH, the niacin therapy earthquake
DOI: 10.1016/j.jacl.2011.10.017
Approximately 57 years ago, niacin became one of the first medications reported to lower cholesterol levels when Rudolf Altschul and coworkers first published results in rabbits. During the next 10 ye...
|
Eliot A. Brinton
|
Editorial
(In Press Uncorrected Proof)
|
11 November 2011 |
|
Lipid levels in obese and nonobese subjects as predictors of fasting and postload glucose metabolism
DOI: 10.1016/j.jacl.2011.09.005
Background: Dyslipidemia in the overweight/obese patient often is associated with impaired glucose metabolism. The authors of large clinical trials in different ethnic groups highlighted the correlati...
|
Stefano Giannini,
Gianluca Bardini,
Ilaria Dicembrini,
Matteo Monami,
Carlo Maria Rotella,
Edoardo Mannucci
et al.
|
Full-length article
(In Press Corrected Proof)
|
03 October 2011 |
|
A multicenter study of nutraceutical drinks for cholesterol (evaluating effectiveness and tolerability)
DOI: 10.1016/j.jacl.2011.09.004
Background: We hypothesized that a nutraceutical formulation containing small amounts of bioactive constituents that exert cholesterol-lowering effects by different mechanisms may exhibit synergistic ...
|
Mitchell Karl,
Mark Rubenstein,
Chad Rudnick,
John Brejda
|
Full-length article
(In Press Corrected Proof)
|
22 September 2011 |
|
A systematic review on evidence of the effectiveness and safety of a wax-matrix niacin formulation
DOI: 10.1016/j.jacl.2011.07.003
Abstract: Niacin is a uniquely efficacious therapy in the treatment of dyslipidemia because of its broad spectrum of beneficial effects on every aspect of the lipid profile and because it has been sho...
|
Andrew P. Dunatchik,
Matthew K. Ito,
Carlos A. Dujovne
|
Full-length article
(In Press Corrected Proof)
|
26 July 2011 |
|
Responses of Authors to the Arguments made in the Point and Counterpoint.
DOI: 10.1016/j.jacl.2008.07.001
|
W. Virgil Brown
|
Discussion
(In Press Accepted Manuscript)
|
14 July 2008 |